1. The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression
   Ho Kyung Seo et al, 2017, Oncotarget CrossRef
2. ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
   Junlan Zhu et al, 2017, Molecular Therapy - Nucleic Acids CrossRef
3. Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles
   Sean K Sweeney et al, 2016, Cancer Nanotechnology CrossRef
4. Expression of bladder cancer‑associated glycans in murine tumor cell lines
   Marina Albert� et al, 2019, Oncology Letters CrossRef
5. Evaluation of the safety and feasibility of electrochemotherapy with intravenous bleomycin as local treatment of bladder cancer in dogs
   Marcelo Monte Mor Rangel et al, 2023, Scientific Reports CrossRef
6. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier
   Patrick Vianna Garcia et al, 2016, BMC Cancer CrossRef
7. Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs
   Christopher M. Fulkerson et al, 2017, International Journal of Genomics CrossRef
8. In Situ Constructed Nano‐Drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer
   Da‐Yong Hou et al, 2022, Angewandte Chemie International Edition CrossRef
9. In Situ Constructed Nano‐Drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer
   Da‐Yong Hou et al, 2022, Angewandte Chemie CrossRef
10. The anti-PD-1 era — an opportunity to enhance radiotherapy for patients with bladder cancer
    Richard C. Walshaw et al, 2018, Nature Reviews Urology CrossRef
11. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
    Tahlita C.M. Zuiverloon et al, 2018, Bladder Cancer CrossRef
12. An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer
    Tomoharu Naito et al, 2019, Oncology Letters CrossRef
13. Effects of Scaffolds on Urine- and Urothelial Carcinoma Tissue-Derived Organoids from Bladder Cancer Patients
    Simon Walz et al, 2023, Cells CrossRef
14. Circular STAG2 RNA Modulates Bladder Cancer Progression via miR-145-5p/TAGLN2 and Is Considered as a Biomarker for Recurrence
    Chris Du et al, 2024, Cancers CrossRef
15. Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans
    Deborah W. Knapp et al, 2020, Frontiers in Oncology CrossRef
16. Establishment of Mouse Orthotopic Urinary Bladder Tumor Model and Its Analysis by Light and Electron Microscopy
    Andreja Erman et al, 2024, Mouse Models of Cancer CrossRef
17. How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model
    Andreja Erman et al, 2019, Histochemistry and Cell Biology CrossRef
18. Hyaluronic Acid-Conjugated Fluorescent Probe-Shielded Polydopamine Nanomedicines for Targeted Imaging and Chemotherapy of Bladder Cancer
    Heping Qiu et al, 2023, ACS Applied Materials & Interfaces CrossRef
19. Non-Invasive Imaging Modalities in Intravesical Murine Models of Bladder Cancer
    Sydney Relouw et al, 2023, Cancers CrossRef
20. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
    Doreen Huebner et al, 2017, BMC Cancer CrossRef
21. Tumor-targeting albumin nanoparticles as an efficacious drug delivery system and potential diagnostic tool in non-muscle-invasive bladder cancer therapy
    Sneha Sree Mullapudi et al, 2022, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
22. Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans
    Wonkyung Oh et al, 2023, Cancer Research Communications CrossRef
23. Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model
    Wagner J. Fávaro et al, 2022, Medical Oncology CrossRef